Seneca Biopharma Inc fka SNCA

[BesaoT35]

CUR used to have a drug in clinical trials called NSI-189. It was a small molecule that does easily cross the blood brain barrier. It has been shown anatomically that it would cause neural growth in the hippocampus. It did show cognitive benefits for patients but missed the mood related psychological endpoints in a depression trial.

I thought that the drug still had potential. I do not however see any recent news about NSI-189. Does any one know anything that they could share about the current status or the potential clinical benefits of NSI-189? Thanks.